GlassScriptPhysician profile
Jennifer B Ward
NPI 1275626780
$2,128.97
in general payments reported to CMS, 2019-2025
19 companies · $344 in 2025
The $344 reported for 2025 was more than what 88% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $318 · 2020: $392 · 2021: $220 · 2022: $324 · 2023: $203 · 2024: $328 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $875.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $341.25 | 2020-2022 | |
| Tris Pharma INC | $281.55 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $244.70 | 2020-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Corium, LLC | $215.06 | 2022-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $161.54 | 2019-2024 | |
| Cranial Technologies, INC | $140.82 | 2019-2025 | Doc Band |
| Supernus Pharmaceuticals, INC. | $116.29 | 2022-2025 | Qelbree |
| Collegium Pharmaceutical, INC. | $103.48 | 2025 | Jornay Pm |
| Pfizer INC. | $101.26 | 2019-2022 | |
| Sanofi Pasteur INC. | $89.28 | 2021-2025 | |
| Glaxosmithkline, LLC. | $83.36 | 2019-2024 | Pediarix, Bexsero, Rotarix |
| Phadia US INC. | $43.45 | 2023-2024 | Immunocap |
| Neos Therapeutics, LP | $43.45 | 2019 | |
| Shire North American Group INC | $39.44 | 2019 | |
| Sanofi-Aventis U.S. LLC | $39.41 | 2024-2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $37.32 | 2025 | Neffy |
| Cipher Pharmaceuticals US LLC | $18.57 | 2025 | Spinosad, Natroba |
| Kaleo, INC. | $17.00 | 2022 | |
| Adlon Therapeutics L.P. | $11.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.